跳至主要内容
临床试验/NCT06389071
NCT06389071招募中不适用

Safety and Efficacy of Ablative Fractional 2940 nm Laser Treatment for Lichen Sclerosus Lesion

Sciton2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Sciton
入组人数
50
试验地点
2
主要终点
Histological clearance

研究概览

简要总结

Fractional ablative laser treatment for Lichen Sclerosus lesion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged 18 years or older
  • Biopsy-proven vulvar lichen sclerosus lesion
  • Experiencing one or more of the following symptoms of LS:
  • Easily bruises
  • Easily tears
  • Ulcerated lesions
  • Painful intercourse
  • Negative urine pregnancy test if subject is of childbearing potential before enrollment
  • Absence of vulvovaginal infection i.e. fungi, bacterial vaginosis, and STI
  • Ability to understand and sign informed consent, questionnaires, and all investigation requirements
  • Willing to consent to clinical photographs of the treatment area
  • Willing to consent to ultrasound images of the treatment area
  • Willing and able to logistically follow schedule of treatments and follow-up visits

排除标准

  • Pregnancy, less than 3 months postpartum, or planning to become pregnant during the investigation to protect integrity of the data
  • Is a nursing mother
  • History of uncontrolled malignant disease
  • Active urogenital infection or chronic infection (i.e., candida, herpes, herpes simplex, bacterial vaginosis, trichomoniasis, or other infection)
  • Immunocompromised (e.g., lymphoma, AIDS, Wiskott-Aldrich syndrome)
  • Subjects with genital skin disease, psoriasis due to risk of koeberizing
  • Subjects on immunosuppressants: mycophenolate, retinoids, azathioprine, cyclosporin
  • Known allergy or intolerance to local anesthesia
  • Known history of connective tissue disease
  • Known propensity for keloid formations
  • Known medical condition that may affect wound healing
  • Any reason that the investigator deems prohibits participation in the investigation

研究组 & 干预措施

Treatment + PRP Arm

Active Comparator

干预措施: Fractional 2940 nm Laser (Device)

Treatment only Arm

Active Comparator

干预措施: Fractional 2940 nm Laser (Device)

结局指标

主要结局

Histological clearance

时间窗: 16 weeks

Efficacy of the treatment is determined by histological changes measured at 16 weeks post final treatment

次要结局

未报告次要终点

研究者

发起方
Sciton
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验